Department of Neurology, University of Texas HSC, McGovern Medical School, Houston.
Stroke. 2024 Jan;55(1):166-176. doi: 10.1161/STROKEAHA.123.045194. Epub 2023 Dec 8.
Within hours after intracerebral hemorrhage (ICH) onset, masses of polymorphonuclear neutrophils (PMNs) infiltrate the ICH-affected brain. After degranulation involving controlled release of many toxic antimicrobial molecules, the PMNs undergo rapid apoptosis and then are removed by phagocytic microglia/macrophages (MΦ) through a process called efferocytosis. Effective removal of PMNs may limit secondary brain damage and inflammation; however, the molecular mechanisms governing these cleanup activities are not well understood. We propose that scavenger receptor CD91 on myeloid phagocytes especially in presence of CD91 ligand, LTF (lactoferrin, protein abundant in PMNs), plays an important role in clearance of dead apoptotic PMNs (ANs).
Mice/rats were subjected to an autologous blood injection model of ICH. Primary cultured microglia were used to assess phagocytosis of ANs. Immunohistochemistry was employed to assess CD91 expression and PMN infiltration. CD91 knockout mice selectively in myeloid phagocytes (Mac-CD91-KO) were used to establish the CD91/LTF function in phagocytosis and in reducing ICH-induced injury, as assessed using behavioral tests, hematoma resolution, and oxidative stress.
Masses of PMNs are found in ICH-affected brain, and they contain LTF. MΦ at the outer border of hematoma are densely packed, expressing CD91 and phagocytosing ANs. Microglia deficient in CD91 demonstrate defective phagocytosis of ANs, and mice deficient in CD91 (Mac-CD91-KO) subjected to ICH injury have increased neurological dysfunction that is associated with impaired hematoma resolution (hemoglobin and iron clearance) and elevated oxidative stress. LTF that normally ameliorates ICH injury in CD91-proficient control mice shows reduced therapeutic effects in Mac-CD91-KO mice.
Our study suggests that CD91 plays a beneficial role in improving ANs phagocytosis and ultimately post-ICH outcome and that the beneficial effect of LTF in ICH is in part dependent on presence of CD91 on MΦ.
脑出血(ICH)发作后数小时内,大量多形核粒细胞(PMN)浸润到ICH 影响的大脑。PMN 脱颗粒后,许多有毒的抗菌分子得到控制释放,PMN 迅速凋亡,然后被吞噬小胶质细胞/巨噬细胞(MΦ)通过一个称为吞噬作用的过程清除。PMN 的有效清除可能限制二次脑损伤和炎症;然而,控制这些清除活动的分子机制尚不清楚。我们提出,髓样吞噬细胞上的清道夫受体 CD91,特别是在 CD91 配体,乳铁蛋白(PMN 中丰富的蛋白质)存在的情况下,在清除死亡凋亡的 PMN(ANs)中发挥重要作用。
将小鼠/大鼠置于自体血注射 ICH 模型中。原代培养的小胶质细胞用于评估 ANs 的吞噬作用。免疫组织化学用于评估 CD91 表达和 PMN 浸润。髓样吞噬细胞中 CD91 敲除(Mac-CD91-KO)的小鼠用于建立 CD91/LTF 在吞噬作用和减少 ICH 诱导损伤中的作用,通过行为测试、血肿消退和氧化应激来评估。
ICH 影响的大脑中发现大量 PMN,其中含有乳铁蛋白。血肿外边界的 MΦ 紧密堆积,表达 CD91 并吞噬 ANs。缺乏 CD91 的小胶质细胞表现出 ANs 吞噬作用缺陷,并且遭受 ICH 损伤的缺乏 CD91(Mac-CD91-KO)的小鼠表现出神经功能障碍增加,这与血肿消退(血红蛋白和铁清除)受损和氧化应激升高有关。正常情况下在 CD91 功能正常的对照小鼠中改善 ICH 损伤的乳铁蛋白在 Mac-CD91-KO 小鼠中显示出降低的治疗效果。
我们的研究表明,CD91 在改善 ANs 吞噬作用和最终 ICH 后结果方面发挥有益作用,乳铁蛋白在 ICH 中的有益作用部分取决于 MΦ 上 CD91 的存在。